BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3032493)

  • 1. Peripheral and autonomic nerve function in long-term insulin-dependent diabetes.
    Ziegler D; Cicmir I; Wiefels K; Berger H; Gries FA
    Diabetes Res; 1987 Jan; 4(1):9-14. PubMed ID: 3032493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes.
    Ziegler D; Cicmir I; Mayer P; Wiefels K; Gries FA
    Klin Wochenschr; 1988 Nov; 66(21):1085-92. PubMed ID: 2853250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic and autonomic nerve function during the first year after diagnosis of type 1 (insulin-dependent) diabetes.
    Ziegler D; Cicmir I; Mayer P; Wiefels K; Gries FA
    Diabetes Res; 1988 Mar; 7(3):123-7. PubMed ID: 3046819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.
    Ziegler D; Wiefels K; Dannehl K; Gries FA
    Klin Wochenschr; 1988 May; 66(9):388-96. PubMed ID: 2839729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.
    Ziegler D; Behler M; Schroers-Teuber M; Roden M
    BMJ Open; 2015 Jun; 5(6):e006559. PubMed ID: 26109108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve function and metabolic control in teenage diabetics.
    Young RJ; Ewing DJ; Clarke BF
    Diabetes; 1983 Feb; 32(2):142-7. PubMed ID: 6298040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients.
    Ziegler D; Buchholz S; Sohr C; Nourooz-Zadeh J; Roden M
    Acta Diabetol; 2015 Feb; 52(1):65-72. PubMed ID: 24898524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus.
    Ziegler D; Mayer P; Mühlen H; Gries FA
    Diabetologia; 1991 Nov; 34(11):822-9. PubMed ID: 1769441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathy.
    Abraham RR; Abraham RM; Wynn V
    Electroencephalogr Clin Neurophysiol; 1986 Mar; 63(3):223-30. PubMed ID: 2419078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.
    Plater ME; Ford I; Dent MT; Preston FE; Ward JD
    Diabetologia; 1996 Mar; 39(3):336-43. PubMed ID: 8721780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction.
    Krönert K; Hülser J; Luft D; Stetter T; Eggstein M
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1219-23. PubMed ID: 3033010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study.
    Amthor KF; Dahl-Jørgensen K; Berg TJ; Heier MS; Sandvik L; Aagenaes O; Hanssen KF
    Diabetologia; 1994 Jun; 37(6):579-84. PubMed ID: 7926342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of epalrestat plus α-lipoic acid combination therapy
    Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
    Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
    Ziegler D; Dannehl K; Wiefels K; Gries FA
    Diabet Med; 1992; 9(7):622-9. PubMed ID: 1511568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acupuncture for distal symmetric multiple peripheral neuropathy of diabetes mellitus: a randomized controlled trial].
    Lu M; Li K; Wang J
    Zhongguo Zhen Jiu; 2016 May; 36(5):481-4. PubMed ID: 27509606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations among autonomic, sensory, and motor neural function tests in untreated non-insulin-dependent diabetic individuals.
    Pfeifer MA; Weinberg CR; Cook DL; Reenan A; Halar E; Halter JB; LaCava EC; Porte D
    Diabetes Care; 1985; 8(6):576-84. PubMed ID: 4075943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
    Tkac I; Bril V
    Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.